(Q33825348)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Autoimmunity and environment: am I at risk? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author

Dimitrios P. Bogdanos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Andrew Kenneth Burroughs

4

object named as

Andrew K Burroughs

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Daniel Smyk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Eirini I Rigopoulou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Harold Baum

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Diego Vergani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

Clinical Reviews in Allergy & Immunology

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

199-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21337133%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12016-011-8259-x

23 January 2020

exact match

0 references

cites work

The etiopathogenesis of autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The genetics and epigenetics of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The genetics of complex autoimmune diseases: non-MHC susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Gender and risk of autoimmune diseases: possible role of estrogenic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Light, including ultraviolet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Infection, vaccines and other environmental triggers of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Infections and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Twin studies in auto-immune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geo-epidemiology and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The consequences of apoptosis in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Drugs and autoimmunity--a contemporary review and mechanistic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Cigarette smoking and autoimmune disease: what can we learn from epidemiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Effects of tobacco smoke on immunity, inflammation and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Is autoimmunity a matter of sex?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Self-mimicking autoimmune domains of hepatitis C virus core antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Viral/self-mimicry and immunological cross-reactivity as a trigger of hepatic C virus associated autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Chronic fatigue syndrome with autoantibodies--the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Occupational and environmental exposures as risk factors for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Occupational exposure to crystalline silica and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Silica-exposed mice generate autoantibodies to apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population- and clinic-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Vitamin D and autoimmunity: new aetiological and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Vitamin D and autoimmune rheumatologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Suppressive effect of 1alpha,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Disease-specific autoantibodies in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Autoimmune liver serology: current diagnostic and clinical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Antimitochondrial and other autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Primary biliary cirrhosis once rare, now common in the United Kingdom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Epidemiology and natural history of primary biliary cirrhosis in a US community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Specificity of anti-sp100 antibody for primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Nuclear envelope protein autoantibodies in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The peculiar autoimmunity of primary biliary cirrhosis

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

21 January 2018

12 December 2020

The causes of primary biliary cirrhosis: Convenient and inconvenient truths

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Pathogenesis of cholestatic liver disease and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Primary biliary cirrhosis: paradigm or paradox for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The immunological milieu of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Risk factors for primary biliary cirrhosis in a cohort of patients from the united states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Bacteriuria and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Significant bacteriuria has prognostic significance in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Bacteria and primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Molecular mimicry and primary biliary cirrhosis: premises not promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Experimental evidence on the immunopathogenesis of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The role of environmental factors in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Susceptibility to thyroid disorders in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Virus, liver and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Hepatitis C virus and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Mitochondrial antigens, molecular mimicry and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The enigma of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Estrogens and the pathophysiology of the biliary tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Prevalence and pattern of familial disease in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Familial primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Familial primary biliary cirrhosis in Hiroshima

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Genes and (auto)immunity in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Natural history of early primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Antimitochondrial antibodies in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Cyclophosphamide: Use in Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Autoimmunity in the era of genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Are we at a stage to predict autoimmune rheumatic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Interpretative comments on autoantibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

A propos time and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Environmental factors and the geoepidemiology of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The epidemiology of transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The geoepidemiology of the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The implications of autoimmunity and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The geoepidemiology of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The geoepidemiology of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Epigenetics and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The immune effects of naturally occurring and synthetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The complement system in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The environment, geoepidemiology and ANCA-associated vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The geoepidemiology of immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology: the environment and spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology of autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology of autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Definition of human autoimmunity--autoantibodies versus autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The geoepidemiology of autoimmune intestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Travels and travails of autoimmunity: a historical journey from discovery to rediscovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The geoepidemiology of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology of myasthenia gravis [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiologic considerations of auto-immune pemphigus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Multiple sclerosis: Geoepidemiology, genetics and the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The geoepidemiology of autoimmune muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Coordination of tolerogenic immune responses by the commensal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology and autoimmune manifestations of lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Autoimmune kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The worldwide gradient of autoimmune conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Nutrition, geoepidemiology, and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Defining and analyzing geoepidemiology and human autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

21 January 2018

Stress and autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Hepatitis C and interferon induced thyroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Geoepidemiology of COPD and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Molecular mimicry in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8259-X

Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression

21 January 2018

1 reference

12 December 2020

Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice

1 reference

12 December 2020

Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis

1 reference

12 December 2020

Primary biliary cirrhosis: an epidemiological study

1 reference

12 December 2020

1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis

1 reference

12 December 2020

Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen

1 reference

12 December 2020

Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis

1 reference

12 December 2020

Twin studies in rheumatic diseases

1 reference

12 December 2020

Primary biliary cirrhosis in mother and daughter

1 reference

12 December 2020

1 reference

12 December 2020

Viruses and cytotoxic T lymphocytes in type 1 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Unusual suspects in primary biliary cirrhosis

1 reference

12 December 2020

HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study

1 reference

12 December 2020

Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis

1 reference

12 December 2020

Increased incidence of menstrual abnormalities and hysterectomy preceding primary biliary cirrhosis

1 reference

12 December 2020

Shared familial aggregation of susceptibility to autoimmune diseases

1 reference

12 December 2020

Prevalence of familial disease in primary biliary cirrhosis in Italy

1 reference

12 December 2020

The role of E. coli infection in the pathogenesis of primary biliary cirrhosis.

1 reference

12 December 2020

Molecular mimicry and autoimmune disease

1 reference

12 December 2020

Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis

1 reference

12 December 2020

Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis

1 reference

12 December 2020

PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis

1 reference

12 December 2020

Pathogenesis of primary biliary cirrhosis

1 reference

12 December 2020

Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis

1 reference

12 December 2020

Anti-Helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies

1 reference

12 December 2020

Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis

1 reference

12 December 2020

1 reference

12 December 2020

The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis

1 reference

12 December 2020

Does vitamin D affect risk of developing autoimmune disease?: a systematic review

1 reference

12 December 2020

Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis

1 reference

12 December 2020

Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?

1 reference

12 December 2020

Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites

1 reference

12 December 2020

Origin of cross-reactive autoimmunity in primary biliary cirrhosis

1 reference

12 December 2020